Nasal spray could replace pills for anxiety during breast surgery, trial hopes
NCT ID NCT07350928
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a medicated nasal spray (dexmedetomidine) can help women feel relaxed and less anxious during breast-conserving surgery for breast cancer. About 394 women will receive either the spray or a placebo before surgery. Researchers will measure sedation levels, pain, and satisfaction to see if the spray improves the surgical experience.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGTianjin, 300060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?